Clinical Trial Update: Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia [Phase 3]

View source ↗

Summary

Open-label phase 3 trial evaluating the combination of amlodipine and atorvastatin in subjects with hypertension and dyslipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypertension

Drugs mentioned

• amlodipine/atorvastatin

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Hypertension, Dyslipidemia | Phase 3 | Status: COMPLETED